| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | — |
| R&D Expense | $367.0M | +23.9% |
| SG&A Expense | $105.9M | +10.4% |
| Operating Income | -$472.1M | -20.4% |
| Pre-tax Income | -$512.9M | -98.8% |
| Income Tax | $139K | +51.1% |
| Net Income | -$513.0M | -98.8% |
| EPS (Basic) | -$0.79 | -79.5% |
| EPS (Diluted) | -$0.79 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204.0M | +39.6% |
| Short-term Investments | $828.2M | -9.1% |
| Current Assets | $1.06B | -2.6% |
| Total Assets | $1.27B | -1.8% |
| Current Liabilities | $45.1M | +49.4% |
| Total Liabilities | $235.1M | +83.3% |
| Stockholders' Equity | $1.03B | -11.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$313.8M | -33.0% |
| Capital Expenditures | $30.6M | -44.3% |
| Investing Cash Flow | $80.3M | +112.7% |
| Financing Cash Flow | $288.2M | +376.8% |
| Free Cash Flow | -$344.4M | -18.4% |
| -79.5% |